TENAX THERAPEUTICS, INC. Other Asset Impairment Charges
TENAX THERAPEUTICS, INC. (TENX) reported Other Asset Impairment Charges of $0 for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OtherAssetImpairmentCharges · last filed 2016-11-09
- TENAX THERAPEUTICS, INC. other asset impairment charges for the quarter ending 2016-09-30 was $0.00.
- TENAX THERAPEUTICS, INC. other asset impairment charges for the quarter ending 2015-09-30 was $0.00.
| Period end | Other Asset Impairment Charges 3 month | Other Asset Impairment Charges 9 month |
|---|---|---|
| 2016-09-30 | $0.00 10-Q · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-09 | $1.03M 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |